spacer
spacer
Go to PDB code: 
protein Protein-protein interface(s) links
Binding protein PDB-id
1ilr
    Jmol     Help!  
Contents
Description
Header details
Header records
References
PROCHECK
Protein chains
145 a.a. *
Waters ×139

* Residue conservation analysis
Tools
Image Generation
AstexViewer™@PDBe
Run PROCHECK
Clefts Calculation
  
PDB id: 1ilr
Name: Binding protein
Title: Crystal structure of the interleukin-1 receptor antagonist

Structure:
Interleukin-1 receptor antagonist protein. Chain: 1, 2. Engineered: yes

Source:
Homo sapiens. Human. Organism_taxid: 9606

UniProt:
Chains 1, 2: P18510 (IL1RA_HUMAN)
Pfam   ArchSchema ?
Seq: 177 a.a.
Struc: 145 a.a.
Key:    PfamA domain
 Secondary structure  CATH domain

Resolution:
2.10Å

R-factor:
0.197

Authors:
H.A.Schreuder,J.-M.Rondeau,C.Tardif

Key ref:
H.A.Schreuder et al. (1995). Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline.. Eur J Biochem, 227, 838-847. [PubMed id: 7867645] [DOI: 10.1111/j.1432-1033.1995.tb20209.x]

Date:
20-Jun-94

Release date:
07-Feb-95
Quick_links
RCSB
PDBe
SRS
MMDB
JenaLib
OCA
PDBWiki
Proteopedia
CATH
SCOP
FSSP
HSSP
PDBSWS
PQS
ProSAT
Whatcheck
EDS
Procheck
Go to PROCHECK summary
Clefts
Clefts
Surface
RasMol surface
spacer
spacer

 
    Key reference    
 
 
DOI no: 10.1111/j.1432-1033.1995.tb20209.x Eur J Biochem 227:838-847 (1995)
PubMed id: 7867645  
 
 
Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline.
H.A.Schreuder, J.M.Rondeau, C.Tardif, A.Soffientini, E.Sarubbi, A.Akeson, T.L.Bowlin, S.Yanofsky, R.W.Barrett.
 
  ABSTRACT  
 
Interleukin-1 (IL-1) molecules are cytokines involved in the acute-phase response against infection and injury. Three naturally occurring IL-1 molecules are known, two agonists: IL-1 alpha and IL-1 beta, and one antagonist, the IL-1 receptor antagonist (IL-1ra). Although IL-1 action protects the organism by enhancing the response to pathogens, its overproduction can lead to pathology and has been implicated in disease states that include septic shock, rheumatoid arthritis, graft versus host disease and certain leukemias. The crystal structure of IL-1ra has been solved at 0.21-nm resolution by molecular replacement using the IL-1 beta structure as a search model. The crystals contain two independent IL-1ra molecules which are very similar. IL-1ra has the same fold as IL-1 alpha and IL-1 beta. The fold consists of twelve beta-strands which form a six-stranded beta-barrel, closed on one side by three beta-hairpin loops. Cys69 and Cys116 are linked via a disulfide bond and Pro53 has been built in the cis-conformation. Comparison of the IL-1ra structure with the IL-1 alpha and IL-1 beta structures present in the Protein Data Bank shows that a putative receptor interaction region, involving the N-terminus up to the beginning of strand beta 1 and the loops D and G, is very different in the three IL-1 molecules. Other putative interaction regions, as identified with mutagenesis studies, are structurally conserved and rigid, allowing precise and specific interactions with the IL-1 receptor.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
19134476 S.Krishnan, and A.A.Raibekas (2009).
Multistep aggregation pathway of human interleukin-1 receptor antagonist: kinetic, structural, and morphological characterization.
  Biophys J, 96, 199-208.  
17924426 J.R.Alford, B.S.Kendrick, J.F.Carpenter, and T.W.Randolph (2008).
High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics.
  J Pharm Sci, 97, 3005-3021.  
17973297 J.R.Alford, S.C.Kwok, J.N.Roberts, D.S.Wuttke, B.S.Kendrick, J.F.Carpenter, and T.W.Randolph (2008).
High concentration formulations of recombinant human interleukin-1 receptor antagonist: I. Physical characterization.
  J Pharm Sci, 97, 3035-3050.  
18305195 R.F.Latypov, D.Liu, K.Gunasekaran, T.S.Harvey, V.I.Razinkov, and A.A.Raibekas (2008).
Structural and thermodynamic effects of ANS binding to human interleukin-1 receptor antagonist.
  Protein Sci, 17, 652-663.  
17914732 Z.Q.Wen, X.Cao, and A.Vance (2008).
Conformation and side chains environments of recombinant human interleukin-1 receptor antagonist (rh-IL-1ra) probed by raman, raman optical activity, and UV-resonance Raman spectroscopy.
  J Pharm Sci, 97, 2228-2241.  
17340198 G.Vergoten, and J.P.Zanetta (2007).
Structural differences between the putative carbohydrate-recognition domains of human IL-1 alpha, IL-1 beta and IL-1 receptor antagonist obtained by in silico modeling.
  Glycoconj J, 24, 183-193.  
17335058 M.B.Seefeldt, C.Crouch, B.Kendrick, and T.W.Randolph (2007).
Specific volume and adiabatic compressibility measurements of native and aggregated recombinant human interleukin-1 receptor antagonist: density differences enable pressure-modulated refolding.
  Biotechnol Bioeng, 98, 476-485.  
17847076 Z.Q.Wen (2007).
Raman spectroscopy of protein pharmaceuticals.
  J Pharm Sci, 96, 2861-2878.  
16258998 E.Y.Chi, B.S.Kendrick, J.F.Carpenter, and T.W.Randolph (2005).
Population balance modeling of aggregation kinetics of recombinant human interleukin-1 receptor antagonist.
  J Pharm Sci, 94, 2735-2748.  
16158260 H.Tan, G.Dan, H.Gong, and L.Cao (2005).
On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli.
  Biotechnol Lett, 27, 1177-1182.  
16081653 M.B.Seefeldt, Y.S.Kim, K.P.Tolley, J.Seely, J.F.Carpenter, and T.W.Randolph (2005).
High-pressure studies of aggregation of recombinant human interleukin-1 receptor antagonist: thermodynamics, kinetics, and application to accelerated formulation studies.
  Protein Sci, 14, 2258-2266.  
15614819 S.Roy, R.Jung, B.A.Kerwin, T.W.Randolph, and J.F.Carpenter (2005).
Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations.
  J Pharm Sci, 94, 382-396.  
15514986 Y.Zhang, S.Roy, L.S.Jones, S.Krishnan, B.A.Kerwin, B.S.Chang, M.C.Manning, T.W.Randolph, and J.F.Carpenter (2004).
Mechanism for benzyl alcohol-induced aggregation of recombinant human interleukin-1 receptor antagonist in aqueous solution.
  J Pharm Sci, 93, 3076-3089.  
11093146 J.L.Barton, R.Herbst, D.Bosisio, L.Higgins, and M.J.Nicklin (2000).
A tissue specific IL-1 receptor antagonist homolog from the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities.
  Eur J Immunol, 30, 3299-3308.  
10328267 J.K.Dattagupta, A.Podder, C.Chakrabarti, U.Sen, D.Mukhopadhyay, S.K.Dutta, and M.Singh (1999).
Refined crystal structure (2.3 A) of a double-headed winged bean alpha-chymotrypsin inhibitor and location of its second reactive site.
  Proteins, 35, 321-331.
PDB code: 2wbc
9597123 W.P.Arend, M.Malyak, C.J.Guthridge, and C.Gabay (1998).
Interleukin-1 receptor antagonist: role in biology.
  Annu Rev Immunol, 16, 27-55.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.